What Does the Manual Reveal About Peramivir Sodium Chloride?
Paramivir Sodium Chloride Injection, an antiviral medication, is a transparent and clarified solution administered via intravenous drip. Its primary constituents are paramivir and sodium chloride, targeted primarily at influenza virus-induced colds. Each bottle contains 100ml, and common adverse reactions may include bronchitis and cough. It's crucial to note that Paramivir Sodium Chloride does not serve as a substitute for the influenza vaccine.
Instructions for Paramivir Sodium Chloride Injection:
Drug Name: Paramivir Sodium Chloride Injection
Indications: As an antiviral drug, it is primarily used to treat ordinary influenza and type A influenza caused by influenza viruses, encompassing H1(H1N.), HA(HAN.), and H9N9 series viruses that induce influenza.
Dosage and Administration: Administered by intravenous drip, treatment should commence within 48 hours of influenza symptom onset. The typical dosage is a single intravenous drip of 300mg, with an infusion duration of no less than 30 minutes.
Ingredients: Contains Paramivir (calculated as C15H28N4O4) 0.3g and Sodium Chloride 0.9g.
Appearance: Paramivir Sodium Chloride Injection presents as a transparent and clarified liquid.
Specification: 100ml/bottle; contains Paramivir Trihydrate (calculated as C15H28N4O4) 0.3g and Sodium Chloride 0.9g.
Adverse Reactions: Primarily bronchitis and cough, with minor adverse effects on the digestive system.
Precautions:
- Certain individuals may require electrocardiographic monitoring during high-dose clinical applications.
- It does not replace the influenza vaccine, and its use should not disrupt annual influenza vaccination schedules.